Ms McLoughlin has served on the boards of a number of ASX50 companies and is a company director with domestic and international experience in financial and health services and telecommunications. She has had ranging experience covering health, insurance, resources, infrastructure and financial services. She is currently Chairman of the Suncorp Group Limited, Chancellor-elect of the University of Wollongong, and is a non-executive director of nib holdings limited.

Mr Daniell has worked in the medical device industry for 40 years and has executive leadership experience. He was Managing Director and CEO of Fisher & Paykel Healthcare Corporation Limited ("Fisher & Paykel Healthcare") from November 2001 to March 2016. Prior to this, Mr Daniell held various technical management and product design roles within Fisher & Paykel Healthcare. Mr Daniell is currently a Non-Executive Director of Fisher & Paykel Healthcare. He is also a Council Member of the University of Auckland and a Non-Executive Director of the Medical Research Commercialisation Fund in Melbourne, Australia. He is also member of Nommination.

Mr Holliday-Smith is the Member of the People & Culture Committees. He has Global executive and leadership experience in capital markets and derivatives, and a background in venture capital activities. He was Former President of NationsBank-CRT, Chicago and Managing Director of Hong Kong Bank Limited, London. He is the director of Servcorp Limited, Non-executive Chairman, QBiotics and member of the Macquarie University Faculty of Business and Economics Advisory Board. He was Chairman, Snowy Hydro Limited and SFE Corporation Limited. Director, St George Bank Limited, Exco Resources NL, DCA Group Limited and MIA Group Limited. He is also the Member of the Audit & Risk committee.

Ms Deans is a company director with experience across a range of industries. During her executive career she held leadership roles as a CEO, strategic advisor and technology investor, including CEO of venture capital firm netus, CEO of technology investment firm ecorp, and was the first CEO of eBay Australia. While a consultant with McKinsey in London and Sydney, she focused on client issues related to innovation and growth. Ms Deans is currently Chair of the Technology & Innovation Committee and a member of Risk and People & Culture Committees of Cochlear. Ms Deans is also serving on the boards of Ramsay Health Care Ltd and Deputy Group Pty Ltd, and on the Investment Committee of MainSequence Ventures (Manager of the CSIRO Innovation Fund). She was formerly on the boards of Insurance Australia Group Limited, Westpac Banking Corporation, ecorp Pty Ltd and Social Ventures Australia.

Mr Denver is the member of the Medical Science, Technology & Innovation Committees. He has experience in the life sciences industry. He was the Managing Director of Memtec Limited and President Asia for Pall Corporation. He is the Chairman of SpeeDx and Director, Vaxxas and QBiotics.

Ms Allen is a member of the People & Culture, Technology & Innovation Committees. He has a career in investment banking with senior roles in strategic analysis and corporate advice. She was Former Vice President of Deutsche Bank AG. She is the Director, Santos Limited, ASX Limited and National Portrait Gallery, Member of the George Institute for Global Health Board. She is also Chairman, Advance (Global Australian Network) and Acting President, Australian Government Takeovers Panel. he was Director, Insurance Australia Group Limited, National director of the Australian Institute of Company Directors; Member of The Salvation Army Advisory Board; Chair of Macquarie Specialised Asset Management; Director, ANZ Investment Bank and Associate Director, HSBC London.

Mr Boreham is the Chairman of the People & Culture Committee, Member of the and Technology & Innovation Committees. He led organisations in information technology, new media and the creative industries through periods of rapid change and innovation. Former Managing Director of IBM Australia and New Zealand. He is also Director, Southern Cross Media Group and Link Group. Chairman, Advisory Board IXUP. He was Director of Data#3. Chairman of Screen Australia, Advance (Global Australian Network), Business School and Industry Advisory Board for the University of Technology, Sydney. He is also the member of Audit & Risk committee.

Professor Robinson is the Chairman of Medical Science Committee, member of the People & Culture and Technology & Innovation Committees. He has over 20 years leadership experience as an academic physician/scientist across research, healthcare and medicine, and tertiary education. He was former Dean, The University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. He is the Chairman, National Health and Medical Research Council and Medical Benefits Schedule Review Taskforce, Director, MaynePharma and QBiotics. He is also member of Nomination Committee.

Mr Howitt has experience across the Company in roles including Chief Operating Officer, SVP, Manufacturing and Logistics and President, Asia Pacific. Prior to joining Cochlear, he worked for Boral and Boston Consulting Group. He is a member of the Medical Science and Technology & Innovation Committees

-

-